Actionable news
All posts from Actionable news
Actionable news in FATE: Fate Therapeutics, Inc.,

Can Fate Therapeutics (FATE) Keep the Earnings Streak Alive This Quarter?

Looking for a stock that might be in a good position to beat earnings at its next report? Consider Fate Therapeutics, Inc. FATE, a firm in the Medicine–Biomedicine/Genetic industry, which could be a great candidate for another beat.

This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, FATE has beaten estimates by at least 10% in both cases, suggesting it has a nice short-term history of crushing expectations.

Earnings in Focus

Two quarters ago, FATE expected to post a loss of 37 cents per share, while it actually produced a loss of 33 cents per share, a beat of 10.8%. Meanwhile...